Drug Markets/SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR

SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR

1 NDCs across 1 manufacturers|0 Generic,1 Brand

Total NDCs

0G / 1B

Manufacturers

competing in market

Price Spread

$858.69 – $858.69

7d Activity

1 flat

of 1 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
VOSEVI 400-100-100 MG TABLET	61958240101	Gilead Sciences, Inc.	$858.6884 per EA	—	Brand	—	Hepatitis C Virus NS3/4A Protease Inhibitor, Hepatitis C Virus NS5A Inhibitor, Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor